Clinical Analysis of 115 Cases: Protective Effect of Hematopoietic Stem Cells on Chemotherapeutic Druginduced Liver Toxicity

LIANG Xu,SONG Guo-hong,DI Li-jun,LU Yuan-li,ZHU Yu-lin,ZHANG Jie,JIA Jun,YAN Ying,REN Jun

DOI: https://doi.org/10.3969/j.issn.1672-8157.2012.01.002

2012-01-01

Abstract:Objective: To investigate the protective effect of hematopoietic stem cells for chemotherapeutic drug-induced acute liver injury.Methods: With the NCI CTC 3.0 adverse drug reactions as the standard version,clinical data of 115 cases with high-dose chemotherapy(HDC) supported by hematopoietic stem cells,from 2005 to 2009 in department of oncology of our hospital were surveyed.Results: There were 40 patients in all of 115 patients,whose liver function improved more or less in the second cycle of HDC with hematopoietic stem cells infusion,compared with that in the previous cycle(P = 0.000),which indicated that the incidence of abnormal liver function was significantly lower in group of HDC combined with hematopoietic stem cells infusion than in simple chemotherapy group.After the first cycle of chemotherapy,incidence of patients with severe hepatic toxicity of grade 2-4 was 13.9%(16 cases),while after the second cycle that was 6.1%(7 cases),and P = 0.048,indicating that the incidence of moderate-severe liver toxicity decreased significantly after the combination use with hematopoietic stem cells.Conclusion: The ALT difference between two cycles chemotherapy and the rate of moderate-severe acute drug-induced liver injury was significantly different in patients with or without hematopoietic stem cells support,and after hematopoietic stem cells infusion,the patients with abnormal liver function in the first cycle recovered significantly.So hematopoietic stem cells may have protective effect on chemotherapeutic drug-induced hepatotoxicity.